Select Publications
By Dr Amit Saha
Journal articles
2024, 'Syphilis point-of-care tests: an Australian perspective', Microbiology Australia, 45, pp. 127 - 131, http://dx.doi.org/10.1071/MA24036
,2024, 'Clinical effectiveness and analytical quality of a national point-of-care testing network for sexually transmitted infections integrated into rural and remote primary care clinics in Australia, 2016–2022: an observational program evaluation', The Lancet Regional Health - Western Pacific, 48, http://dx.doi.org/10.1016/j.lanwpc.2024.101110
,2024, 'Measles, mumps, rubella and varicella antibodies among international and domestic university students', Journal of Travel Medicine, 31, http://dx.doi.org/10.1093/jtm/taae004
,2023, 'Flexible and Innovative Connectivity Solution to Support National Decentralized Infectious Diseases Point-of-Care Testing Programs in Primary Health Services: Descriptive Evaluation Study', Journal of Medical Internet Research, 25, http://dx.doi.org/10.2196/46701
,2022, 'Causes of death through verbal autopsy: Findings from a sub-study of single dose oral cholera vaccination in urban Dhaka, Bangladesh', Journal of Global Health Reports, 6, http://dx.doi.org/10.29392/001c.35322
,2021, 'Seroprevalence of hepatitis B antibodies among international and domestic university students', Journal of Viral Hepatitis, 28, pp. 1400 - 1412, http://dx.doi.org/10.1111/jvh.13580
,2021, 'Gut microbiota and development of vibrio cholerae-specific long-term memory b cells in adults after whole-cell killed oral cholera vaccine', Infection and Immunity, 89, http://dx.doi.org/10.1128/IAI.00217-21
,2021, 'A decentralised point-of-care testing model to address inequities in the COVID-19 response', The Lancet Infectious Diseases, 21, pp. e183 - e190, http://dx.doi.org/10.1016/S1473-3099(20)30859-8
,2019, 'Feasibility, coverage and cost of oral cholera vaccination conducted by icddr,b using the existing national immunization service delivery mechanism in rural setting Keraniganj, Bangladesh', Human Vaccines and Immunotherapeutics, 15, pp. 1302 - 1309, http://dx.doi.org/10.1080/21645515.2018.1528833
,2019, 'Safety of a bivalent, killed, whole-cell oral cholera vaccine in pregnant women in Bangladesh: Evidence from a randomized placebo-controlled trial', BMC Infectious Diseases, 19, http://dx.doi.org/10.1186/s12879-019-4006-3
,2019, 'Organization and implementation of an oral cholera vaccination campaign in an endemic urban setting in Dhaka, Bangladesh', Global Health Action, 12, http://dx.doi.org/10.1080/16549716.2019.1574544
,2018, 'Socioeconomic drivers of vaccine uptake: An analysis of the data of a geographically defined cluster randomized cholera vaccine trial in Bangladesh', Vaccine, 36, pp. 4742 - 4749, http://dx.doi.org/10.1016/j.vaccine.2018.04.084
,2018, 'Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial', The Lancet Infectious Diseases, 18, pp. 666 - 674, http://dx.doi.org/10.1016/S1473-3099(18)30108-7
,2017, 'Socioeconomic risk factors for cholera in different transmission settings: An analysis of the data of a cluster randomized trial in Bangladesh', Vaccine, 35, pp. 5043 - 5049, http://dx.doi.org/10.1016/j.vaccine.2017.07.021
,2017, 'Safety of the oral cholera vaccine in pregnancy: Retrospective findings from a subgroup following mass vaccination campaign in Dhaka, Bangladesh', Vaccine, 35, pp. 1538 - 1543, http://dx.doi.org/10.1016/j.vaccine.2017.01.080
,2017, 'Improving immunization approaches to cholera', Expert Review of Vaccines, 16, pp. 235 - 248, http://dx.doi.org/10.1080/14760584.2017.1249470
,2017, 'Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic country', Vaccine, 35, pp. 321 - 328, http://dx.doi.org/10.1016/j.vaccine.2016.11.055
,2016, 'Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children', PLoS Neglected Tropical Diseases, 10, http://dx.doi.org/10.1371/journal.pntd.0005039
,2016, 'How to use faecal calprotectin in management of paediatric inflammatory bowel disease', ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION, 101, pp. 124 - 128, http://dx.doi.org/10.1136/archdischild-2014-307941
,2016, 'Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh', New England Journal of Medicine, 374, pp. 1723 - 1732, http://dx.doi.org/10.1056/NEJMoa1510330
,2016, 'The oral cholera vaccine Shanchol™ when stored at elevated temperatures maintains the safety and immunogenicity profile in Bangladeshi participants', Vaccine, 34, pp. 1551 - 1558, http://dx.doi.org/10.1016/j.vaccine.2016.02.020
,2015, 'Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: A cluster randomised open-label trial', The Lancet, 386, pp. 1362 - 1371, http://dx.doi.org/10.1016/S0140-6736(15)61140-0
,2015, 'Estimating the cost of cholera-vaccine delivery from the societal point of view: A case of introduction of cholera vaccine in Bangladesh', Vaccine, 33, pp. 4916 - 4921, http://dx.doi.org/10.1016/j.vaccine.2015.07.042
,2015, 'Diarrheal illness and healthcare seeking behavior among a population at high risk for diarrhea in Dhaka, Bangladesh', PLoS ONE, 10, http://dx.doi.org/10.1371/journal.pone.0130105
,2014, 'Coverage and acceptability of cholera vaccine among high-risk population of urban Dhaka, Bangladesh', Vaccine, 32, pp. 5690 - 5695, http://dx.doi.org/10.1016/j.vaccine.2014.08.021
,2014, 'Response on letter by Arya et al.: "Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh."', Vaccine, 32, pp. 4014, http://dx.doi.org/10.1016/j.vaccine.2014.03.099
,2014, 'Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh', Vaccine, 32, pp. 1055 - 1060, http://dx.doi.org/10.1016/j.vaccine.2014.01.001
,2014, 'Immunogenicity of a Killed Bivalent (O1 and O139) Whole Cell Oral Cholera Vaccine, Shanchol, in Haiti', PLoS Neglected Tropical Diseases, 8, http://dx.doi.org/10.1371/journal.pntd.0002828
,2013, 'Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh', Vaccine, 31, pp. 6058 - 6064, http://dx.doi.org/10.1016/j.vaccine.2013.10.021
,2013, 'Infection: mass vaccination is feasible in response to cholera epidemics', Nature reviews. Gastroenterology & hepatology, 10, pp. 700 - 701, http://dx.doi.org/10.1038/nrgastro.2013.217
,2013, 'Cost of illness for cholera in a high risk urban area in Bangladesh: An analysis from household perspective', BMC Infectious Diseases, 13, http://dx.doi.org/10.1186/1471-2334-13-518
,2013, 'Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh', Clinical and Vaccine Immunology, 20, pp. 780 - 788, http://dx.doi.org/10.1128/CVI.00035-13
,2013, 'Knowledge of, attitudes toward, and preventive practices relating to cholera and oral cholera vaccine among urban high-risk groups: Findings of a cross-sectional study in Dhaka, Bangladesh', BMC Public Health, 13, http://dx.doi.org/10.1186/1471-2458-13-242
,2013, 'Vaccine specific immune response to an inactivated oral cholera vaccine and EPI vaccines in a high and low arsenic area in Bangladeshi children', Vaccine, 31, pp. 647 - 652, http://dx.doi.org/10.1016/j.vaccine.2012.11.049
,2012, 'Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired cholera', Clinical and Vaccine Immunology, 19, pp. 1304 - 1311, http://dx.doi.org/10.1128/CVI.00196-12
,2012, 'Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh (Clinical and Vaccine Immunology (2012) 19, 5, (690-698))', Clinical and Vaccine Immunology, 19, pp. 1337, http://dx.doi.org/10.1128/CVI.00299-12
,2012, 'Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh', Clinical and Vaccine Immunology, 19, pp. 690 - 698, http://dx.doi.org/10.1128/CVI.05615-11
,2011, 'Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age', Vaccine, 29, pp. 8285 - 8292, http://dx.doi.org/10.1016/j.vaccine.2011.08.108
,2011, 'Corrigendum to "Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: A randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age" [Vaccine 29 (2011) 1855-1858]', Vaccine, 29, pp. 6068, http://dx.doi.org/10.1016/j.vaccine.2011.06.108
,2011, 'Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: A randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age', Vaccine, 29, pp. 1855 - 1858, http://dx.doi.org/10.1016/j.vaccine.2010.12.133
,2010, 'Immune responses to Helicobacter pylori infection in Bangladeshi children during their first two years of life and the association between maternal antibodies and onset of infection', Journal of Infectious Diseases, 202, pp. 1676 - 1684, http://dx.doi.org/10.1086/657085
,2010, 'The added benefit of zinc supplementation after zinc treatment of acute childhood diarrhoea: A randomized, double-blind field trial', Tropical Medicine and International Health, 15, pp. 754 - 761, http://dx.doi.org/10.1111/j.1365-3156.2010.02525.x
,2010, 'Zinc influences innate immune responses in children with enterotoxigenic Escherichia coli-induced diarrhea', Journal of Nutrition, 140, pp. 1049 - 1056, http://dx.doi.org/10.3945/jn.109.111492
,2010, 'A fatal cobra-bite in a snake expert.', Mymensingh medical journal : MMJ, 19, pp. 303 - 307
,2009, 'Salmonella enterica serovar typhi-specific immunoglobulin A antibody responses in plasma and antibody in lymphocyte supernatant specimens in Bangladeshi patients with suspected typhoid fever', Clinical and Vaccine Immunology, 16, pp. 1587 - 1594, http://dx.doi.org/10.1128/CVI.00311-09
,2009, 'Infection by Helicobacter pylori in Bangladeshi children from birth to two years: Relation to blood group, nutritional status, and seasonality', Pediatric Infectious Disease Journal, 28, pp. 79 - 85, http://dx.doi.org/10.1097/INF.0b013e31818a5d9d
,2008, 'Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea', Clinical Infectious Diseases, 47, pp. 797 - 803, http://dx.doi.org/10.1086/591130
,2007, 'Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh', Infection and Immunity, 75, pp. 3961 - 3968, http://dx.doi.org/10.1128/IAI.00459-07
,2007, 'Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants', Vaccine, 25, pp. 231 - 238, http://dx.doi.org/10.1016/j.vaccine.2006.08.031
,2005, 'Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh', Journal of Infectious Diseases, 192, pp. 573 - 579, http://dx.doi.org/10.1086/432074
,